Clinical Trial 46427

Winter Haven, FL 33880


The purpose of this study, which involves research, is to determine whether an investigational drug, ABP-450 (prabotulinumtoxinA), is safe and effective to treat migraine patients, compared with the placebo. ABP 450 is a toxin produced by a bacterium called Clostridium botulinum. ABP-450 is similar to botulinum toxin (Botox® ). This toxin has been used in small amounts by doctors to treat health problems. In this study, ABP-450 is being tested in people who have more than 6 migraines in a month.

Qualified Participants Must:

• Be at least 18 years of age
• Get at least 6 migraines per month on average

Qualified Participants May Receive:

- Study related care such as blood work and EKG

- Compensation for time and travel expenses

- Physical performed by a board certified physician

Available At:

Clinical Research of Central Florida
500 East Central Ave
Winter Haven, FL 33880
View Clinic Location


If you or someone you care for is interested in participating and lives within 25 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.